Centessa Pharmaceuticals Q2 EPS $(0.69) Down From $(0.65) YoY

Centessa Pharmaceuticals (NASDAQ:CNTA) reported quarterly losses of $(0.69) per share. This is a 6.15 percent decrease over losses of $(0.65) per share from the same period last year.